Leprosy Review · 1989 · 22 citations · 7 references
MedicineDermatologyPharmacotherapyAllergyDermatopathologyHypersensitivityDrug-induced Skin ReactionsImmunopathology Of SkinInfectious DermatosesInflammatory Skin DisordersSkin InfectionsDapsone TherapyDermal Hypersensitivity ReactionDrug-induced ErythrodermaEmollient UseNail Matrix InvolvementTherapeutic CorticosteroidsTopical EmollientsUrgent Referral Criteria
A 35-year-old female with borderline lepromatous (BL) leprosy who suffered from dapsone-induced erythroderma is reported. Sudden onset of erythroderma gave rise to a temporary arrest of the function of nail matrix with the resultant Beau's lines. She rapidly recovered with omission of dapsone and therapy with systemic corticosteroids and a topical emollient. In view of the potentially fatal hypersensitivity reaction, we suggest that any patient on multidrug therapy for leprosy needs an urgent referral to a dermatologist if the patient develops a skin rash during the first two months of treatment.
7
FINGERNAIL GROWTH IN NORMAL AND PSORIATIC SUBJECTS
R.P.R. DAWBER · British Journal of Dermatology · 1970 · 87 citations
Gordon C. Sauer · Journal of the American Academy of Dermatology · 1982 · 43 citations · Full text
Side-effects of antileprosy drugs in common use
W. H. Jopling · Leprosy Review · 1983 · 33 citations · Full text
Multiple Beau's lines due to dysmenorrhoea?
Graham Colver, R.P.R. DAWBER · British Journal of Dermatology · 1984 · 24 citations
J. Frank Fraser · Archives of Dermatology and Syphilology · 1943 · 24 citations
Medicine, Dermatology, Oncology +8